Common Stock, Shares, Outstanding of Lyell Immunopharma, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Lyell Immunopharma, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Lyell Immunopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 21,251,353, a 44% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Lyell Immunopharma, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 21,251,353 +6,507,576 +44% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 19,293,951 -237,269,733 -92% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 14,830,868 -241,117,465 -94% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 295,283,653 +40,356,773 +16% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 14,743,777 -239,213,932 -94% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 256,563,684 +4,694,716 +1.9% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 255,948,333 +4,921,336 +2% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 254,926,880 +5,317,633 +2.1% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 253,957,709 +4,390,366 +1.8% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 251,868,968 +2,629,135 +1.1% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 251,026,997 +3,917,111 +1.6% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 249,609,247 +4,186,398 +1.7% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 249,567,343 +6,828,993 +2.8% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 249,239,833 +9,450,833 +3.9% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 247,109,886 +8,560,886 +3.6% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 245,422,849 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 242,738,350 +227,168,562 +1459% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 239,789,000 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 238,549,000 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q4 2020 15,569,788 31 Dec 2020 10-K 29 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.